The risk of neoplasms in patients treated with cyclosporine A
- 31 October 1989
- journal article
- Published by Elsevier in Journal of Autoimmunity
- Vol. 2 (5), 723-731
- https://doi.org/10.1016/s0896-8411(89)80010-1
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- EFFECTS OF IMMUNOSUPPRESSIVE THERAPY ON THE INDUCTION OF SKIN TUMORS BY ULTRAVIOLET IRRADIATION IN HAIRLESS MICETransplantation, 1987
- CANCERS FOLLOWING CYCLOSPORINS THERAPYTransplantation, 1987
- Kutan-noduläres Kaposi-Sarkom nach Nierentransplantation und ImmunsuppressionKlinische Wochenschrift, 1984
- Epstein-barr virus-induced lymphoma in a cardiac transplant recipientAmerican Journal Of Medicine, 1984
- REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPYThe Lancet, 1984
- LONG-TERM T-CELL-MEDIATED IMMUNITY TO EPSTEIN-BARR VIRUS IN RENAL-ALLOGRAFT RECIPIENTS RECEIVING CYCLOSPORIN AThe Lancet, 1981
- CYCLOSPORIN A IMMUNOSUPPRESSION, EPSTEIN-BARR ANTIBODY, AND LYMPHOMAThe Lancet, 1980
- Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs.BMJ, 1979
- CYCLOSPORIN A INITIALLY AS THE ONLY IMMUNOSUPPRESSANT IN 34 RECIPIENTS OF CADAVERIC ORGANS: 32 KIDNEYS, 2 PANCREASES, AND 2 LIVERSThe Lancet, 1979
- RISK OF CANCER IN RENAL-TRANSPLANT RECIPIENTSThe Lancet, 1973